OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis
Taro Kishi, Ikuo Nomura, Yuki Matsuda, et al.
Journal of Psychiatric Research (2020) Vol. 128, pp. 68-74
Closed Access | Times Cited: 79
Taro Kishi, Ikuo Nomura, Yuki Matsuda, et al.
Journal of Psychiatric Research (2020) Vol. 128, pp. 68-74
Closed Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses
Falk Leichsenring, Christiane Steinert, Sven Rabung, et al.
World Psychiatry (2022) Vol. 21, Iss. 1, pp. 133-145
Open Access | Times Cited: 295
Falk Leichsenring, Christiane Steinert, Sven Rabung, et al.
World Psychiatry (2022) Vol. 21, Iss. 1, pp. 133-145
Open Access | Times Cited: 295
Insomnia
Eliza L. Sutton
Annals of Internal Medicine (2021) Vol. 174, Iss. 3, pp. ITC33-ITC48
Closed Access | Times Cited: 167
Eliza L. Sutton
Annals of Internal Medicine (2021) Vol. 174, Iss. 3, pp. ITC33-ITC48
Closed Access | Times Cited: 167
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
Emmanuel Mignot, David Mayleben, Ingo Fietze, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 2, pp. 125-139
Closed Access | Times Cited: 145
Emmanuel Mignot, David Mayleben, Ingo Fietze, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 2, pp. 125-139
Closed Access | Times Cited: 145
Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis
Jing-Li Yue, Xiang-Wen Chang, Jun-Wei Zheng, et al.
Sleep Medicine Reviews (2023) Vol. 68, pp. 101746-101746
Closed Access | Times Cited: 49
Jing-Li Yue, Xiang-Wen Chang, Jun-Wei Zheng, et al.
Sleep Medicine Reviews (2023) Vol. 68, pp. 101746-101746
Closed Access | Times Cited: 49
The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis
Tao Xue, Xin Wu, Shujun Chen, et al.
Sleep Medicine Reviews (2021) Vol. 61, pp. 101573-101573
Closed Access | Times Cited: 68
Tao Xue, Xin Wu, Shujun Chen, et al.
Sleep Medicine Reviews (2021) Vol. 61, pp. 101573-101573
Closed Access | Times Cited: 68
A 2023 Update on Managing Insomnia in Primary Care
Russell Rosenberg, Ruth M. Benca, Paul P. Doghramji, et al.
The Primary Care Companion For CNS Disorders (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 24
Russell Rosenberg, Ruth M. Benca, Paul P. Doghramji, et al.
The Primary Care Companion For CNS Disorders (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 24
Insomnia and Other Sleep Disorders in Older Adults
Zachary Cohen, Paul M. Eigenberger, Katherine M. Sharkey, et al.
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 4, pp. 717-734
Closed Access | Times Cited: 29
Zachary Cohen, Paul M. Eigenberger, Katherine M. Sharkey, et al.
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 4, pp. 717-734
Closed Access | Times Cited: 29
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study
Motohiro Ozone, Susumu Hirota, Yu Ariyoshi, et al.
Advances in Therapy (2024) Vol. 41, Iss. 4, pp. 1728-1745
Open Access | Times Cited: 7
Motohiro Ozone, Susumu Hirota, Yu Ariyoshi, et al.
Advances in Therapy (2024) Vol. 41, Iss. 4, pp. 1728-1745
Open Access | Times Cited: 7
Emerging and upcoming therapies in insomnia
W.-H. Kim, Ho-Sook Kim
Translational and Clinical Pharmacology (2024) Vol. 32, Iss. 1, pp. 1-1
Open Access | Times Cited: 6
W.-H. Kim, Ho-Sook Kim
Translational and Clinical Pharmacology (2024) Vol. 32, Iss. 1, pp. 1-1
Open Access | Times Cited: 6
The Effect of Suvorexant on Fear Extinction Recall: A Double‐Blind Randomised Controlled Pilot Trial in Healthy Individuals
Maya T. Schenker, Lilith Z. Zeng, J Lynskey, et al.
Journal of Sleep Research (2025)
Open Access
Maya T. Schenker, Lilith Z. Zeng, J Lynskey, et al.
Journal of Sleep Research (2025)
Open Access
Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis
Heather McElroy, Beth O’Leary, Michael Adena, et al.
Journal of Managed Care & Specialty Pharmacy (2021) Vol. 27, Iss. 9, pp. 1296-1308
Open Access | Times Cited: 28
Heather McElroy, Beth O’Leary, Michael Adena, et al.
Journal of Managed Care & Specialty Pharmacy (2021) Vol. 27, Iss. 9, pp. 1296-1308
Open Access | Times Cited: 28
Association of orexin receptor antagonists with falls during hospitalization
Rintaro Sogawa, Akiko Emoto, Akira Monji, et al.
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 6, pp. 809-813
Closed Access | Times Cited: 21
Rintaro Sogawa, Akiko Emoto, Akira Monji, et al.
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 6, pp. 809-813
Closed Access | Times Cited: 21
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Effects of different interventions on insomnia in adults: Systematic review and network meta-analysis
Shu‐wen Wang, Yueyan Lan, Z H Liu, et al.
Journal of Psychiatric Research (2023) Vol. 165, pp. 140-149
Closed Access | Times Cited: 11
Shu‐wen Wang, Yueyan Lan, Z H Liu, et al.
Journal of Psychiatric Research (2023) Vol. 165, pp. 140-149
Closed Access | Times Cited: 11
New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Αθανάσιος Αλεξίου, et al.
Neurological Sciences (2024) Vol. 45, Iss. 5, pp. 2367-2368
Open Access | Times Cited: 4
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Αθανάσιος Αλεξίου, et al.
Neurological Sciences (2024) Vol. 45, Iss. 5, pp. 2367-2368
Open Access | Times Cited: 4
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
Taro Kishi, Maika Nishida, Michinori Koebis, et al.
Neuropsychopharmacology Reports (2021) Vol. 41, Iss. 4, pp. 450-458
Open Access | Times Cited: 23
Taro Kishi, Maika Nishida, Michinori Koebis, et al.
Neuropsychopharmacology Reports (2021) Vol. 41, Iss. 4, pp. 450-458
Open Access | Times Cited: 23
Network meta-analysis comparing the effectiveness of a prescription digital therapeutic for chronic insomnia to medications and face-to-face cognitive behavioral therapy in adults
Felicia Forma, Ramya Pratiwadi, Fadoua El Moustaid, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 10, pp. 1727-1738
Open Access | Times Cited: 17
Felicia Forma, Ramya Pratiwadi, Fadoua El Moustaid, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 10, pp. 1727-1738
Open Access | Times Cited: 17
Evaluation of the delirium preventive effect of dual orexin receptor antagonist (DORA) in critically ill adult patients requiring ventilation with tracheal intubation at an advanced emergency center: A single-center, retrospective, observational study
Ayaka Matsuoka, Rintaro Sogawa, Toru Murakawa‐Hirachi, et al.
General Hospital Psychiatry (2023) Vol. 83, pp. 123-129
Open Access | Times Cited: 9
Ayaka Matsuoka, Rintaro Sogawa, Toru Murakawa‐Hirachi, et al.
General Hospital Psychiatry (2023) Vol. 83, pp. 123-129
Open Access | Times Cited: 9
A Comprehensive Review of Lemborexant to Treat Insomnia.
Mitchell C. Fuller, Samuel F. Carlson, Chris M. Grant, et al.
PubMed (2024) Vol. 54, Iss. 1, pp. 43-64
Closed Access | Times Cited: 3
Mitchell C. Fuller, Samuel F. Carlson, Chris M. Grant, et al.
PubMed (2024) Vol. 54, Iss. 1, pp. 43-64
Closed Access | Times Cited: 3
Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial
Yoshikazu Takaesu, Masahiro Suzuki, Margaret Moline, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 4, pp. 581-592
Open Access | Times Cited: 15
Yoshikazu Takaesu, Masahiro Suzuki, Margaret Moline, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 4, pp. 581-592
Open Access | Times Cited: 15
Medications Used for Pediatric Insomnia
Vijayabharathi Ekambaram, Judith Owens
Child and Adolescent Psychiatric Clinics of North America (2020) Vol. 30, Iss. 1, pp. 85-99
Closed Access | Times Cited: 21
Vijayabharathi Ekambaram, Judith Owens
Child and Adolescent Psychiatric Clinics of North America (2020) Vol. 30, Iss. 1, pp. 85-99
Closed Access | Times Cited: 21
Medications Used for Pediatric Insomnia
Vijayabharathi Ekambaram, Judith Owens
Psychiatric Clinics of North America (2024) Vol. 47, Iss. 1, pp. 87-101
Closed Access | Times Cited: 2
Vijayabharathi Ekambaram, Judith Owens
Psychiatric Clinics of North America (2024) Vol. 47, Iss. 1, pp. 87-101
Closed Access | Times Cited: 2
